Description
| Specialty | BIVAL | 
|---|---|
| Dosage | 80 mg / 12.5 mg | 
| Form | Film-coated tablet | 
| Presentation | Box of 30 | 
| Primary packaging | Blister | 
| Specification | Alu/Alu | 
| Active Ingredients (DCI) | Hydrochlorothiazide, Valsartan | 
| VEIC Classification | Essential | 
| Therapeutic Class | Cardiovascular System | 
| Subclass | Agents acting on the renin-angiotensin system | 
| Laboratory | PHILADELPHIA PHARMA | 
| Table | A | 
| Shelf life | 24 months | 
| Generic / Brand | Generic | 
| Marketing Authorization (AMM) | 9353131 | 
| AMM Date | 2015-07-06 | 
| Product Range | Cardio-Metabolic Range | 







Reviews
There are no reviews yet.